The Prostate

Cover image for The Prostate

1 April 2005

Volume 63, Issue 1

Pages 1–103

  1. Original Articles

    1. Top of page
    2. Original Articles
    1. Immunological evaluation of individualized peptide vaccination with a low dose of estramustine for HLA-A24+ HRPC patients (pages 1–12)

      Masanori Noguchi, Kyogo Itoh, Akihisa Yao, Takashi Mine, Akira Yamada, Yayoi Obata, Masatoshi Furuta, Mamoru Harada, Shigetaka Suekane and Kei Matsuoka

      Version of Record online: 17 SEP 2004 | DOI: 10.1002/pros.20157

    2. Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue (pages 13–18)

      Thomas Steuber, Pauliina Niemela, Alexander Haese, Kim Pettersson, Andreas Erbersdobler, K.-H. Felix Chun, Markus Graefen, Michael W. Kattan, Hartwig Huland and Hans Lilja

      Version of Record online: 17 SEP 2004 | DOI: 10.1002/pros.20156

    3. Androgen receptor levels in prostate cancer epithelial and peritumoral stromal cells identify non-organ confined disease (pages 19–28)

      Carmela Ricciardelli, Catherine S. Choong, Grant Buchanan, Suchindra Vivekanandan, Petra Neufing, Jürgen Stahl, Villis R. Marshall, David J. Horsfall and Wayne D. Tilley

      Version of Record online: 17 SEP 2004 | DOI: 10.1002/pros.20154

    4. Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism (pages 29–43)

      Rosa M. Sainz, Juan C. Mayo, Dun-xian Tan, Josefa León, Lucien Manchester and Russel J. Reiter

      Version of Record online: 17 SEP 2004 | DOI: 10.1002/pros.20155

    5. Vasoactive intestinal peptide induces neuroendocrine differentiation in the LNCaP prostate cancer cell line through PKA, ERK, and PI3K (pages 44–55)

      Irene Gutiérrez-Cañas, María G. Juarranz, Beatriz Collado, Nieves Rodríguez-Henche, Antonio Chiloeches, Juan C. Prieto and María J. Carmena

      Version of Record online: 5 OCT 2004 | DOI: 10.1002/pros.20173

    6. Effectiveness of adjuvant intermittent endocrine therapy following neoadjuvant endocrine therapy and external beam radiation therapy in men with locally advanced prostate cancer (pages 56–64)

      Hidetoshi Yamanaka, Kazuto Ito, Seiji Naito, Taiji Tsukamoto, Michiyuki Usami, Hiroyuki Fujimoto, Naoki Matsuoka, Iwao Fukui, Masaoki Harada, Yasuo Ohashi, Toshihiko Kotake and Tadao Kakizoe

      Version of Record online: 5 OCT 2004 | DOI: 10.1002/pros.20171

    7. β3 integrins facilitate matrix interactions during transendothelial migration of PC3 prostate tumor cells (pages 65–80)

      Xiaowei Wang, Alexander M. Ferreira, Qing Shao, Dale W. Laird and Martin Sandig

      Version of Record online: 5 OCT 2004 | DOI: 10.1002/pros.20168

    8. Establishment and characterization of a human primary prostate carcinoma cell line, HH870 (pages 91–103)

      Senthamil R. Selvan, Andrew N. Cornforth, Nagesh P. Rao, Yvonne A. Reid, Patric M. Schiltz, Ray P. Liao, David T. Price, F. Scott Heinemann and Robert O. Dillman

      Version of Record online: 5 OCT 2004 | DOI: 10.1002/pros.20162